ALLELIC GSTS GENE POLYMORPHISM IN MOTHERS WITH PLACENTAL DYSFUNCTION AND THEIR NEWBORNS: OBSTETRIC AND PERINATAL OUTCOMES

Authors

  • M. I. Rymarchuk Ivano-Frankivsk National Medical University
  • O. M. Makarchuk Ivano-Frankivsk National Medical University
  • O. G. Boychuk Ivano-Frankivsk National Medical University

DOI:

https://doi.org/10.11603/2415-8798.2017.1.7464

Keywords:

placental dysfunction, genes polymorphism GSTS, intrauterine growth retardation.

Abstract

Summary. The role of the placenta caused by the implementation of a number of functional mechanisms of growth and fetal development. Glutathione-S-transferase is actively involved in the removal of products peroxidation lipid peroxides and DNA, restoring organic hydroperoxide to alcohol and contributing isomerization some steroids and prostaglandins. If there are certain polymorphic variants GSTT1, GSTM1, GSTP1 gene family of glutathione-S-transferase is hlutation dependent AOD depletion and inhibition of detoxification function of the placenta.

The aim of the study – to determine the allelic polymorphism gene glutathione-S-transferase GSTT1 and GSTM1 in women with placental dysfunction in healthy newborns and infants with intrauterine growth retardation conducted molecular genetic study of umbilical cord blood.

Materials and Methods. The study involved 105 women; the main group included 33 women with placental dysfunction (PD) without intrauterine growth retardation (IUGR) in children born by them (I group) and 17 women with IUGR, and PD (II group). The control group consisted of 55 women (III group) who gave birth to healthy term infants.

Results and Discussion. It is established that the risk of PD and PD with IUGR by the dominant model of inheritance (313AG + 313GG versus 313AA) significantly increased. The promising prognostication models of intergenic interaction for the assessment of the development of placental dysfunction imply the analysis of GSTM1 and GSTP1 gene polymorphisms and for the assessment of the development of placental dysfunction with intrauterine growth retardation – of GSTT1, GSTM1 and GSTP1. An analysis of serum samples of umbilical cord blood and obtained data revealed that the frequency of GSTM1 polymorphic variant "+" in the field of newborns was 42.69 % and GSTM1 "–" – 57.30 %. The frequency of polymorphic variants GSTT1 «+» in all newborns region was 79.77 % and GSTT1 “–“ – 20.22 %.

Conclusions. The study of the distribution of different allelic variants of genes GSTM1 and GSTT1 proved their differences in different groups of newborns. We found significant difference between the frequencies of GSTM1 gene deletion variant in healthy infants and newborns with IUGR. A pooled analysis of the combined impact of several factors found that pregnancy in women with PD, preeclampsia and GSTM1deletion genotype is associated with a significant increased risk of IUGR fetuses.

References

Gluckman, P.D., & Hanson, M.A. (2006). The consequences of being born small–an adaptive perspective. Horm. Res. (65), 5-14.

Rossner, P.Jr., Tabashidze, N., & Dostal, M. (2011). Genetic, Biochemical, and Environmental Factors Associated with Pregnancy Outcomes in Newborns from the Czech Republic. Environ. Health Perspect. 2, (119), 265-271.

Somers, C.M, & Cooper, D.N. (2009). Air pollution and mutations in the germline: are humans at risk? Hum. Genet. 2, (125), 119-130.

Sharp, N.P., & Agrawal, A.F. (2012). Evidence for elevated mutation rates in low-quality genotypes. Proc. Natl. Acad. Sci. U S A. 16, (109), 6142-6146.

Scheuplein, R., Charnley, G., & Dourson, M. (2002). Differential sensitivity of children and adults to chemical toxicity. I. Biological basis. Regul. Toxicol. Pharmacol. 3, (35), 429-447.

Saenger, P., Czernichow, P., Hughes, I., & Reiter, E.O. (2007). Small for gestational age: short stature and beyond. Endocr. Rev. 2, (28), 219-251.

Holland, N., Fucic, A., Merlo, D.F., Sram, R., & Kirsch-Volders, M. (2011). Micronuclei in neonates and children: effects of environmental, genetic, demographic and disease variables. Mutagenesis. 1, (26), 51-56.

El-Zein, R.A, Schabath, M.B, Etzel, C.J, Lopez, M.S, Franklin, J.D, & Spitz M.R. (2006). Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 66, 6449-6456.

Dhillon, V.S., Thomas, P., & Iarmarcovai, G. (2011). Genetic polymorphisms of genes involved in DNA repair and metabolism influence micronucleus frequencies in human peripheral blood lymphocytes. Mutagenesis. 1, (26), 33-42.

Mielzynska-Svach, D., Blaszczyk, E., Butkiewicz, D. (2013). Influence of genetic polymorphisms on biomarkers of exposure and effects in children living in Upper Silesia. Mutagenesis, 5, (28), 591-599.

Hayes, J.D., Flanagan, J.U., Jowsey, I.R. (2005). Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. (45), 51-88.

Arand, M., Muhlbauer, R., & Hengstler, J.A (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem. (236), 184-186.

Gorovenko, N.G., Shunko, E.E., Rossokha, Z.I., Kovaliova, O.M., & Pokhylko, V.I. (2010). Analiz vnesku polimorfnykh variantiv gheniv GSTT1, GSTM1, GSTP1 u rozvytok krytychnykh staniv ta orghannykh dysfunkcij u nedonoshenykh novonarodzhenykh z nyzjkoju masoju tila [Analysis of the contribution of polymorphic variants of genes GSTT1, GSTM1, GSTP1 and the development of critical care and organ dysfunction and premature infants with low birth weight]. Zdorovia zhinky – Woman’s Health, 5, (51). 176-179.

Mates, J., Peres-Gomez, C., & Nunez de Casrto, I. (1999). Antioxidant enzyme and human diseases. Clin. Biochem. (32), 595-603.

Published

2017-04-27

How to Cite

Rymarchuk, M. I., Makarchuk, O. M., & Boychuk, O. G. (2017). ALLELIC GSTS GENE POLYMORPHISM IN MOTHERS WITH PLACENTAL DYSFUNCTION AND THEIR NEWBORNS: OBSTETRIC AND PERINATAL OUTCOMES. Bulletin of Scientific Research, (1). https://doi.org/10.11603/2415-8798.2017.1.7464

Issue

Section

OBSTETRICS AND GYNECOLOGY